FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

109133001: Product containing daclizumab (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173668019 Daclizumab en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
608568012 Daclizumab (substance) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
1185618012 Daclizumab (product) en Fully specified name Inactive Entire term case sensitive (core metadata concept) SNOMED CT core
3524336013 Product containing daclizumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3524337016 Product containing daclizumab en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3665808018 Daclizumab product en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3714244013 Daclizumab-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3378321000005118 daclizumab da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing daclizumab (medicinal product) Is a Product containing monoclonal antibody (product) true Inferred relationship Some
Product containing daclizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Daclizumab (substance) true Inferred relationship Some 1
Product containing daclizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Monoclonal antibody false Inferred relationship Some
Product containing daclizumab (medicinal product) Is a murin-humant monoklonalt IgG-antistof false Inferred relationship Some
Product containing daclizumab (medicinal product) Is a Product containing immunomodulator (product) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
daclizumab 25 mg/5 ml koncentrat til infusionsvæske Is a False Product containing daclizumab (medicinal product) Inferred relationship Some
Daclizumab 25mg/5 mL solution Is a False Product containing daclizumab (medicinal product) Inferred relationship Some
daclizumab 25 mg/5 ml koncentrat til infusionsvæske Is a False Product containing daclizumab (medicinal product) Inferred relationship Some
Daclizumab 25mg/5mL conventional release solution for injection Is a False Product containing daclizumab (medicinal product) Inferred relationship Some
Product containing only daclizumab (medicinal product) Is a True Product containing daclizumab (medicinal product) Inferred relationship Some
Product containing daclizumab in parenteral dose form (medicinal product form) Is a True Product containing daclizumab (medicinal product) Inferred relationship Some

This concept is not in any reference sets

Back to Start